Shanghai Pharmaceuticals Holding Co Ltd (601607) — Free Cash Flow Generation Index
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Free Cash Flow Generation Index of 0.69x as of September 2025. Free cash flow of CN¥1.07 Billion represents 1% of operating cash flow (CN¥1.56 Billion). See Shanghai Pharmaceuticals Holding Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Pharmaceuticals Holding Co Ltd Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Shanghai Pharmaceuticals Holding Co Ltd across 27 annual periods. Explore 601607 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Shanghai Pharmaceuticals Holding Co Ltd (1999–2025)
Year-by-year Free Cash Flow Generation Index for Shanghai Pharmaceuticals Holding Co Ltd. For the full company profile including market capitalisation, see Shanghai Pharmaceuticals Holding Co Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | CN¥3.83 Billion | CN¥6.15 Billion | CN¥2.33 Billion | ▲ +5.8% |
| 2024 | 0.59x | CN¥3.43 Billion | CN¥5.83 Billion | CN¥2.40 Billion | ▲ +36.1% |
| 2023 | 0.43x | CN¥2.26 Billion | CN¥5.23 Billion | CN¥2.97 Billion | ▼ -0.4% |
| 2022 | 0.43x | CN¥2.06 Billion | CN¥4.74 Billion | CN¥2.68 Billion | ▲ +133.0% |
| 2021 | 0.19x | CN¥942.55 Million | CN¥5.06 Billion | CN¥4.12 Billion | ▼ -66.8% |
| 2020 | 0.56x | CN¥3.83 Billion | CN¥6.84 Billion | CN¥3.01 Billion | ▲ +3.2% |
| 2019 | 0.54x | CN¥3.27 Billion | CN¥6.02 Billion | CN¥2.75 Billion | ▲ +42.8% |
| 2018 | 0.38x | CN¥1.19 Billion | CN¥3.14 Billion | CN¥1.94 Billion | ▲ +57.0% |
| 2017 | 0.24x | CN¥641.54 Million | CN¥2.65 Billion | CN¥2.01 Billion | ▲ +373.1% |
| 2016 | -0.09x | CN¥-172.62 Million | CN¥1.95 Billion | CN¥2.12 Billion | ▲ +67.8% |
| 2015 | -0.28x | CN¥-371.30 Million | CN¥1.35 Billion | CN¥1.72 Billion | ▼ -932.0% |
| 2014 | 0.03x | CN¥44.18 Million | CN¥1.34 Billion | CN¥1.29 Billion | ▼ -52.9% |
| 2013 | 0.07x | CN¥68.39 Million | CN¥973.45 Million | CN¥905.06 Million | ▼ -81.7% |
| 2012 | 0.38x | CN¥441.87 Million | CN¥1.15 Billion | CN¥708.91 Million | ▼ -49.9% |
| 2011 | 0.77x | CN¥1.36 Billion | CN¥1.77 Billion | CN¥413.54 Million | ▲ +13.8% |
| 2010 | 0.67x | CN¥1.14 Billion | CN¥1.69 Billion | CN¥550.30 Million | ▼ -23.4% |
| 2009 | 0.88x | CN¥584.17 Million | CN¥664.13 Million | CN¥79.97 Million | ▲ +28.7% |
| 2008 | 0.68x | CN¥195.18 Million | CN¥285.68 Million | CN¥90.50 Million | ▲ +12.6% |
| 2007 | 0.61x | CN¥296.66 Million | CN¥488.94 Million | CN¥192.29 Million | ▼ -18.0% |
| 2006 | 0.74x | CN¥431.51 Million | CN¥583.11 Million | CN¥151.60 Million | ▲ +143.2% |
| 2005 | -1.71x | CN¥-125.09 Million | CN¥73.00 Million | CN¥198.09 Million | ▲ +45.2% |
| 2004 | -3.13x | CN¥-192.72 Million | CN¥61.66 Million | CN¥254.38 Million | ▲ +99.1% |
| 2003 | -349.18x | CN¥-169.10 Million | CN¥484.27K | CN¥169.58 Million | ▼ -19616.5% |
| 2002 | -1.77x | CN¥-178.59 Million | CN¥100.84 Million | CN¥279.44 Million | ▼ -47.4% |
| 2001 | -1.20x | CN¥-78.97 Million | CN¥65.73 Million | CN¥144.71 Million | ▼ -3520.7% |
| 2000 | 0.04x | CN¥5.14 Million | CN¥146.22 Million | CN¥141.09 Million | ▼ -94.8% |
| 1999 | 0.68x | CN¥112.20 Million | CN¥164.67 Million | CN¥52.48 Million | — |